Shabir Madhi to Infant, Newborn, Diseases
This is a "connection" page, showing publications Shabir Madhi has written about Infant, Newborn, Diseases.
Connection Strength
4,362
-
Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa. Clin Infect Dis. 2019 10 30; 69(10):1789-1796.
Score: 0,636
-
Experience and challenges on influenza and pertussis vaccination in pregnant women. Hum Vaccin Immunother. 2018; 14(9):2183-2188.
Score: 0,583
-
Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections. Curr Opin Infect Dis. 2016 06; 29(3):262-7.
Score: 0,502
-
Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLoS One. 2015; 10(4):e0123014.
Score: 0,464
-
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013 Aug 28; 31 Suppl 4:D52-7.
Score: 0,415
-
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants. N Engl J Med. 2023 04 20; 388(16):1533-1534.
Score: 0,202
-
The association between early-onset sepsis and neonatal encephalopathy. J Perinatol. 2022 Mar; 42(3):354-358.
Score: 0,185
-
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med. 2020 07 30; 383(5):426-439.
Score: 0,168
-
Serocorrelates of protection against infant group B streptococcus disease. Lancet Infect Dis. 2019 05; 19(5):e162-e171.
Score: 0,151
-
Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines. Expert Rev Vaccines. 2018 07; 17(7):635-651.
Score: 0,145
-
Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S152-S159.
Score: 0,139
-
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S160-S172.
Score: 0,139
-
Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S173-S189.
Score: 0,139
-
Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S200-S219.
Score: 0,139
-
Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016 Oct; 16(10):e202-e213.
Score: 0,128
-
Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa. Pediatr Infect Dis J. 2012 Aug; 31(8):821-6.
Score: 0,096
-
Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012 Jul; 55(1):91-102.
Score: 0,094
-
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations. Vaccine. 2019 05 27; 37(24):3190-3198.
Score: 0,038